Environmental

INFU provides no disclosed TTM R&D intensity in the supplied metrics, limiting evidence of peer-leading environmental innovation versus medtech peers with clearer product stewardship disclosure.

The available metrics do not show direct emissions, energy, or waste advantages, so its environmental positioning remains harder to verify than peers with broader sustainability reporting.

Low leverage can indirectly support environmental investment capacity, but the absence of explicit climate or resource-use metrics prevents a stronger relative ESG assessment.

Because the dataset is sparse on environmental disclosures, INFU appears broadly average versus peers rather than structurally advantaged on material environmental factors.

Social

INFU’s gross margin and modest stock-based compensation suggest some operational discipline, but these metrics do not directly demonstrate superior employee or patient-related social practices versus peers.

The lack of disclosed workforce, safety, product quality, or supply-chain metrics limits confidence that INFU outperforms medtech peers on the most material social issues.

Moderate leverage can reduce balance-sheet stress that might otherwise pressure staffing or service continuity, yet this is only an indirect social support relative to peers.

Overall social positioning looks middling because the available data show no clear controversy, but also no evidence of standout labor, safety, or customer-protection practices.

Governance

INFU’s debt-to-equity ratio of 0.39 and net debt-to-EBITDA of 0.98 indicate comparatively restrained leverage, which usually supports stronger governance discipline than more levered peers.

Stock-based compensation at 3.5% of revenue appears moderate, suggesting less dilution pressure than peers with heavier equity pay structures and cleaner capital-allocation alignment.

The absence of visible governance red flags in the supplied metrics, combined with conservative leverage, supports a stronger relative governance profile.

While not enough to imply elite governance, the available data point to a disciplined capital structure that is better than many small-cap healthcare peers.

Overall Score

INFU’s ESG profile is mixed, with stronger governance supported by conservative leverage, while environmental and social positioning remain only moderately differentiated due to limited disclosure.

Score Driver: Conservative Leverage And Moderate Equity Compensation Support Governance, But Sparse Environmental And Social Disclosure Caps The Overall Relative ESG Score.